CVS CVS HEALTH Corp

Price (delayed)

$61

Market cap

$76.58B

P/E Ratio

10.68

Dividend/share

$2.6

EPS

$5.71

Enterprise value

$148.57B

CVS Health is an American healthcare company that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; Aetna, a health insurance provider, among many other brands. ...

Highlights
CVS's price to earnings (P/E) is 40% lower than its 5-year quarterly average of 17.0 and 38% lower than its last 4 quarters average of 16.6
The revenue has grown by 9% YoY
CVS HEALTH's EPS has surged by 81% YoY but it has decreased by 12% QoQ
The net income has surged by 79% year-on-year but it has declined by 12% since the previous quarter
CVS's quick ratio is down by 11% YoY and by 8% QoQ
CVS's gross margin is down by 10% YoY

Key stats

What are the main financial stats of CVS
Market
Shares outstanding
1.26B
Market cap
$76.58B
Enterprise value
$148.57B
Valuations
Price to book (P/B)
1.04
Price to sales (P/S)
0.21
EV/EBIT
11.76
EV/EBITDA
11.76
EV/Sales
0.41
Earnings
Revenue
$360.94B
EBIT
$12.63B
EBITDA
$12.63B
Free cash flow
$8.14B
Per share
EPS
$5.71
Free cash flow per share
$6.46
Book value per share
$58.78
Revenue per share
$286.46
TBVPS
$102.94
Balance sheet
Total assets
$249.74B
Total liabilities
$175.59B
Debt
$81.79B
Equity
$73.97B
Working capital
-$15.85B
Liquidity
Debt to equity
1.11
Current ratio
0.81
Quick ratio
0.54
Net debt/EBITDA
5.7
Margins
EBITDA margin
3.5%
Gross margin
14.9%
Net margin
2%
Operating margin
3.5%
Efficiency
Return on assets
2.9%
Return on equity
9.8%
Return on invested capital
10.7%
Return on capital employed
7.6%
Return on sales
3.5%
Dividend
Dividend yield
4.26%
DPS
$2.6
Payout ratio
45.5%

CVS stock price

How has the CVS HEALTH stock price performed over time
Intraday
4.01%
1 week
2.4%
1 month
0.61%
1 year
-18.77%
YTD
-22.75%
QTD
3.28%

Financial performance

How have CVS HEALTH's revenue and profit performed over time
Revenue
$360.94B
Gross profit
$53.62B
Operating income
$12.57B
Net income
$7.32B
Gross margin
14.9%
Net margin
2%
The net income has surged by 79% year-on-year but it has declined by 12% since the previous quarter
The net margin has soared by 67% YoY but it has contracted by 13% from the previous quarter
The operating income has surged by 60% year-on-year but it has declined by 9% since the previous quarter
The company's operating margin rose by 46% YoY but it fell by 8% QoQ

Growth

What is CVS HEALTH's growth rate over time

Valuation

What is CVS HEALTH stock price valuation
P/E
10.68
P/B
1.04
P/S
0.21
EV/EBIT
11.76
EV/EBITDA
11.76
EV/Sales
0.41
CVS HEALTH's EPS has surged by 81% YoY but it has decreased by 12% QoQ
CVS's price to earnings (P/E) is 40% lower than its 5-year quarterly average of 17.0 and 38% lower than its last 4 quarters average of 16.6
CVS's price to book (P/B) is 29% less than its 5-year quarterly average of 1.4 and 23% less than its last 4 quarters average of 1.3
CVS's equity is up by 3.6% YoY but it is down by 3.3% QoQ
The stock's price to sales (P/S) is 33% less than its 5-year quarterly average of 0.3 and 33% less than its last 4 quarters average of 0.3
The revenue has grown by 9% YoY

Efficiency

How efficient is CVS HEALTH business performance
CVS's ROE has soared by 72% YoY but it is down by 13% QoQ
The return on assets has surged by 61% year-on-year but it has declined by 15% since the previous quarter
CVS HEALTH's return on invested capital has surged by 53% YoY but it has decreased by 9% QoQ
CVS HEALTH's return on sales has increased by 46% YoY but it has decreased by 10% QoQ

Dividends

What is CVS's dividend history
DPS
$2.6
Dividend yield
4.26%
Payout ratio
45.5%
Recent dividends

Financial health

How did CVS HEALTH financials performed over time
CVS HEALTH's total assets is 42% more than its total liabilities
The current ratio has declined by 12% year-on-year and by 6% since the previous quarter
CVS's quick ratio is down by 11% YoY and by 8% QoQ
The debt is 11% more than the equity
The debt has grown by 7% YoY and by 3% from the previous quarter
CVS HEALTH's debt to equity has increased by 7% QoQ and by 3.7% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.